The aim of this study was to test whether the perioperative composition of intestinal microbiota can contribute to variable outcomes following vertical sleeve gastrectomy (VSG).
Although bariatric surgery is the most effective treatment for obesity, metabolic outcomes are variable.
Diet-induced obese mice were randomized to VSG or sham surgery, with or without exposure to antibiotics that selectively suppress mainly gram-positive (fidaxomicin, streptomycin) or gram-negative (ceftriaxone) bacteria on postoperative days (POD) 1-4. Fecal microbiota was characterized before surgery and on POD 7 and 28. Mice were metabolically characterized on POD 30-32 and euthanized on POD 35.
VSG resulted in weight loss and shifts in the intestinal microbiota composition relative to sham-operated mice. Antibiotic exposure resulted in sustained reductions in alpha (within-sample) diversity of microbiota and shifts in its composition. All antibiotic treatments proved to be detrimental to metabolic VSG outcomes, regardless of antimicrobial specificity of antibiotics. These effects involved functionally distinct pathways. Specifically, fidaxomicin and streptomycin markedly altered hepatic bile acid signaling and lipid metabolism, while ceftriaxone resulted in greater reduction of key antimicrobial peptides. However, VSG mice exposed to antibiotics, regardless of their specificity, had significantly increased subcutaneous adiposity and impaired glucose homeostasis without changes in food intake relative to control VSG mice.
Dysbiosis induced by brief perioperative antibiotic exposure attenuates weight loss and metabolic improvement following VSG. Potential mechanisms include disruption of bile acid homeostasis and reduction in the production of gut antimicrobial peptides. Results of this study implicate the intestinal microbiota as an important contributor to metabolic homeostasis and a potentially modifiable target influencing clinical outcomes following VSG.
*Department of Surgery, University of Minnesota, Minneapolis, MN
†BioTechnology Institute, University of Minnesota, St. Paul, MN
‡Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN
§Research Animal Resources, University of Minnesota, Minneapolis, MN
¶Department of Medicine, University of Minnesota, Minneapolis, MN.
Reprints: Sayeed Ikramuddin, MD, Department of Surgery, University of Minnesota, 420 Delaware St. SE, Minneapolis, MN 55455. E-mail: Ikram001@umn.edu.
All the senior authors Michael J. Sadowsky, Alexander Khoruts, and Sayeed Ikramuddin contributed equally.
This study received American Diabetes Association [ADA 7-11-ST-01], and Minnesota's Discovery, Research and InnoVation Economy grant from the University of Minnesota.
The authors report no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.annalsofsurgery.com).